Nephros Profit Margin

The latest profit margin for NEPH is 4.06% as of March 2026. That compares with 5.16% in the prior-year period — down 21.4% year over year. That is below the Healthcare sector average of 15.52%. Investors often review this figure alongside Nephros's historical trend and sector peers before judging valuation or financial health.

Over the past year, NEPH's profit margin moved from 5.16% to 4.06% — a 21.4% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Nephros's valuation or profitability profile.

Against Healthcare companies, NEPH currently prints 4.06% for profit margin, while the sector average sits near 15.52%. That is roughly 73.9% below the sector mean. Large gaps often invite a closer look at Nephros's growth, margins, and balance sheet.

Profit Margin shows how effectively Nephros converts resources into returns. At 4.06%, NEPH may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with 5.16% in the prior-year period — down 21.4% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting NEPH's profit margin (4.06%), review year-over-year change from 5.16%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.